Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
Conventional chemotherapy has partial therapeutic effects against hematological malignancies and is correlated with serious side effects and great risk of relapse. Recently, immunotherapeutic drugs have provided encouraging results in the treatment of hematological malignancies. Several immunotherap...
Guardado en:
Autores principales: | Alessandro Allegra, Mario Di Gioacchino, Alessandro Tonacci, Claudia Petrarca, Sebastiano Gangemi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e16d2736b1346818e4c1b5fb7421730 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Alessandro Allegra, et al.
Publicado: (2021) -
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Zhengli Xu, et al.
Publicado: (2021) -
Metallic Nanoparticle-Mediated Immune Cell Regulation and Advanced Cancer Immunotherapy
por: Adityanarayan Mohapatra, et al.
Publicado: (2021) -
Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Sara Small, et al.
Publicado: (2021) -
Commercial utilities and future perspective of nanomedicines
por: Rishabha Malviya, et al.
Publicado: (2021)